Otros idiomas Green Cross Medical Science Corporation

Acciones

A142280

KR7142280007

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 24/05/2024			Varia. Cinco días.	Varia. 1 de enero.
4.085 ^KRW	0,00 %		-0,37 %	-14,36 %

2023

Green Cross Medical Science Corporation informa de los resultados del primer trimestre finalizado el 31 de marzo de 2023

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Green Cross Medical Science Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Green Cross Medical Science Corporation announced that it has received KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors	04/02/22
Green Cross Medical Science Corporation announced that it expects to receive KRW 30 billion in funding from Daishin Securities Co. Ltd., Investment Arm and other investors	27/01/22
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08/02/21
Hemotune AG announced that it has received CHF 5.1 million in funding from Green Cross Medical Science Corporation, ZKB Start-up Finance, Occident Group AG	23/07/20
Green Cross Medical Science Enters into Co-Development Agreement with GeneCast to Develop A New COVID-19 Detection Kit	24/03/20
GreenCross Medical Science Corp. cancelled the acquisition of additional 29.54% stake in CERAGEM Medisys, Inc.	17/04/19
GreenCross Medical Science Corp. agreed to acquire additional 29.54% stake in CERAGEM Medisys, Inc for KRW 4.6 billion.	17/04/18
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from KB Securities Co., Ltd., Investment Arm and other investors	05/01/18
GreenCross Medical Science Corp. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors	05/01/18
GreenCross Medical Science Corp. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Industrial Bank of Korea, Investment Arm, and other investors	03/01/18
GreenCross Medical Science Corp. announced that it expects to receive funding from KB Securities Co., Ltd., Investment Arm and other investors	03/01/18
Tranche Update on GreenCross Medical Science Corp.'s Equity Buyback Plan announced on March 2, 2017.	15/05/17
GreenCross Medical Science Corp.'s Equity Buyback announced on March 2, 2017 has closed with 50,000 shares, representing 0.52% for KRW 536.95 million.	10/05/17
GreenCross Medical Science Corp. announces an Equity Buyback for 50,000 shares.	02/03/17
GreenCross Medical Science Corp. authorizes a Buyback Plan.	02/03/17
GreenCross Medical Science Corp. completed the acquisition of 21.06% stake in CERAGEM Medisys, Inc.	31/01/15
GreenCross Medical Science Corp. agreed to acquire a 21.06% stake in CERAGEM Medisys, Inc. for KRW 5 billion.	20/01/15
GreenCross Medical Science Corp. has completed an IPO in the amount of KRW 12.00 billion.	15/12/14
GreenCross Medical Science Corp. has filed an IPO in the amount of KRW 11.20 billion.	17/09/14

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Green Cross Medical Science Corporation

Acciones

A142280

KR7142280007

Otros idiomas

Filtros